20
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs

&
Pages 251-256 | Published online: 09 Jan 2014

References

  • Kanavos P. The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings . Pharmacoeconomics18(6), 523–532 (2000).
  • Burstall ML. Europe after 1992: implications for pharmaceuticals . Health Affairs9, 157–171 (1991).
  • Ganslandt M, Maskus K. Parallel imports and the pricing of pharmaceutical products: evidence from the European Union . J. Health Economics23, 1035–1057 (2004).
  • Maskus K, Chen Y. Vertical price control and parallel imports: theory and evidence . Rev. Int Economics12(4), 551–570 (2004).
  • European Federation of Pharmaceutical Industries and Associations . The Pharmaceutical Industry in Figures. EFPIA, Brussels, Belgium, 1–27 (2005).
  • The Association of the British Pharmaceutical Industry . Parallel Trade in Medicines. ABFI, London, UK (2007)
  • Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality Mossialos E, Mrazek M, Wally T (Eds). Open University Press. European Observatory on Health Systems and Policies Series, Brussels, Belgium (2004).
  • Kotzian P. Pharmaceutical R&D setting of incomplete European integration . Int. J. Economics Business11(2), 177–195 (2004).
  • Lopez-Casasnovas G, Puig-Junoy J. Review of the literature on reference pricing . Health Policy54(2), 87–123 (2000).
  • Stargardt T, Schreyogg J. Impact of cross-reference pricing on pharmaceutical prices: manufacturers’ pricing strategies and price regulation . Appl. Health Economics Health Policy5(4), 235–247 (2006).
  • Kyle MK. Pharmaceutical price controls and entry strategies . Rev. Economics Stat.89(1), 88–99 (2007).
  • Danzon PM, Furukawa MF. Prices and availability of pharmaceuticals: evidence from nine countries . Health Affairs22(6), W521–W536 (2003).
  • Danzon PM, Chao LW. Cross-national price differences for pharmaceuticals: how large, and why? J. Health Economics19, 159–195 (2000).
  • Organisation for Economic Co-operation and Development, Health Division . A Comparative Analysis of 30 Countries. OECD HD, MA, USA (2003).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.